- Home
- ZNTL vs MCFT Comparison
ZNTL vs MCFT Comparison
Compare ZNTL & MCFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZNTL
- MCFT
- Stock Information
- Founded
- ZNTL 2014
- MCFT 1968
- Country
- ZNTL United States
- MCFT United States
- Employees
- ZNTL N/A
- MCFT N/A
- Industry
- ZNTL Biotechnology: Pharmaceutical Preparations
- MCFT Marine Transportation
- Sector
- ZNTL Health Care
- MCFT Industrials
- Exchange
- ZNTL Nasdaq
- MCFT Nasdaq
- Market Cap
- ZNTL 238.2M
- MCFT 303.7M
- IPO Year
- ZNTL 2020
- MCFT 2015
- Fundamental
- Price
- ZNTL $3.12
- MCFT $16.72
- Analyst Decision
- ZNTL Buy
- MCFT Buy
- Analyst Count
- ZNTL 7
- MCFT 5
- Target Price
- ZNTL $10.86
- MCFT $19.20
- AVG Volume (30 Days)
- ZNTL 1.2M
- MCFT 147.1K
- Earning Date
- ZNTL 11-04-2024
- MCFT 11-06-2024
- Dividend Yield
- ZNTL N/A
- MCFT N/A
- EPS Growth
- ZNTL N/A
- MCFT N/A
- EPS
- ZNTL N/A
- MCFT 0.46
- Revenue
- ZNTL $40,560,000.00
- MCFT $366,588,000.00
- Revenue This Year
- ZNTL N/A
- MCFT N/A
- Revenue Next Year
- ZNTL N/A
- MCFT $16.55
- P/E Ratio
- ZNTL N/A
- MCFT $36.68
- Revenue Growth
- ZNTL N/A
- MCFT N/A
- 52 Week Low
- ZNTL $2.83
- MCFT $16.23
- 52 Week High
- ZNTL $18.24
- MCFT $24.05
- Technical
- Relative Strength Index (RSI)
- ZNTL 44.34
- MCFT 35.69
- Support Level
- ZNTL $2.92
- MCFT $17.08
- Resistance Level
- ZNTL $3.23
- MCFT $17.65
- Average True Range (ATR)
- ZNTL 0.17
- MCFT 0.43
- MACD
- ZNTL 0.00
- MCFT -0.00
- Stochastic Oscillator
- ZNTL 38.33
- MCFT 21.11
About ZNTL Zentalis Pharmaceuticals Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on discovering and developing small molecule therapeutics targeting fundamental biological pathways of cancers. It uses a drug discovery engine, which it refers to as an Integrated Discovery Engine, to identify targets and develop small molecule new chemical entities, or NCEs, with properties that it believes could result in potentially differentiated product profiles. It has two lead product candidates under pipeline: ZN-c5, for the treatment of advanced estrogen receptor-positive, human epidermal growth factor receptor 2-negative, or ER+/HER2-, advanced or metastatic breast cancer; and ZN-c3, for the treatment of advanced solid tumors as monotherapy and ovarian cancer.
About MCFT MasterCraft Boat Holdings Inc.
MasterCraft Boat Holdings Inc designs, manufactures, and markets performance sport boats and outboard boats. The company is based in the United States and operates in three brand-specific segments. The MasterCraft segment generates the majority of the company's revenue and includes inboard boats for water skiing, wakeboarding, and wake surfing. The Pontoon segment produces pontoon boats at its Owosso, Michigan facility. Pontoon boats are used for general recreational boating. The Aviara segment produces luxury day boats at its Merritt Island, Florida facility. Aviara boats are used for general recreational boating.